Comparative Anticoagulant Therapy Of Acute Coronary Syndrome Without St-Segment Elevation In Young Men
F. O. Khasanjanova , Samarkand State Medical Institute, Samarkand Branch Of The Republican Scientific Center Of Emergency Medical Care, Uzbekistan E. N. Tashkenbaeva , Samarkand State Medical Institute, Samarkand Branch Of The Republican Scientific Center Of Emergency Medical Care, Uzbekistan N. N. Radjabov , Samarkand State Medical Institute, Samarkand Branch Of The Republican Scientific Center Of Emergency Medical Care, Uzbekistan G. H. Khalilov , Samarkand State Medical Institute, Samarkand Branch Of The Republican Scientific Center Of Emergency Medical Care, Uzbekistan O. Urazov , Samarkand State Medical Institute, Samarkand Branch Of The Republican Scientific Center Of Emergency Medical Care, UzbekistanAbstract
The comparative effectiveness of enoxiparin sodium and non-fractional heparin (NPH) in the treatment of acute coronary syndrome (ACS) in young men was studied. 100 patients with ACS were examined on the basis of the Samarkand branch of the Republican Scientific Center for Emergency Medical Care from 2018 to 2020. The average age of the patients was 34±5 years. The patients were divided into 2 groups. The first group consisted of 54 men who received anticoagulant therapy with enoxiparin sodium at a dose of 1 mg / kg after 12 hours of 0.5 mg/kg. The second group consisted of 46 men who received NSF, with the first dose of 10,000 units administered intravenously by bolus, and then-5000 units 6 hours subcutaneously.
Keywords
Anticoagulants, acute coronary syndrome, young age, non-fractional heparin, enoxiparin sodium
References
Kashtalap V. V., Barbarash O. L. Actual problems of antithrombotic therapy in acute coronary syndrome (based on the materials of the European Congress of Cardiologists 2017) / / Medical Council. - 2017. - no. 12.
Muinova, K. K., Tashkenbayeva, E. N., Majidova, G. T., Alieva, N. K., Istamova, S. S. (2019). The role of risk factors in the development of myocardial infarction in young men, depending on the family history. Achievements of science and education, (11 (52)).
Moiseev S. V. Selection of antiplatelet / anticoagulant therapy for patients with atrial fibrillation after acute coronary syndrome //Clinical pharmacology and therapy. - 2019. - Vol. 28. - no. 1. - p. 18-25.
Syrov A.V., Zyryanov S. K. Anticoagulant therapy in acute coronary syndrome without ST segment elevation //Atherothrombosis. – 2009. – №. 2.
Tashkent, E. N., Majidova, G. T., Istamova, S. S., & Salieva, I. I. (2020). Changes in heart rate in acute myocardial infarction according to echocardiography of the heart. Scientific journal, (7 (52)).
Tashkent, E. N., Khasanjanova, F. O., Khaidarova, D. D., & Abdullaev, K. Z. (2019). Adverse risk factors affecting the progression of coronary heart disease. Eurasian Journal of Cardiology, (S1).
Tashkenbayeva E. N., Khasanjanova F. O., Abdullaev K. Z. Risk factors for cardiovascular complications in patients with acute coronary syndrome with ST segment elevation //Science and society in an era of change. – 2018. – №. 1. – P. 15-19.
Tatarintseva Z. G., Kosmacheva E. D., Porkhanov V. A. Anticoagulant therapy in atrial fibrillation against the background of acute coronary syndrome in real clinical practice according to the total register of acute coronary syndrome in the Krasnodar territory //Cardiology. - 2018. - Vol. 58. - no. 7S – - p. 55-64.
Khasanjanova F. O., Mardonov U. A. U., Yusupov T. S. U. Factors adversely affecting the outcome of treatment of patients with acute coronary syndrome in young and old age //Problems of modern science and education. – 2019. – №. 11-1 (144).
Khasanjanova F. O. et al. Adverse risk factors affecting the outcome of treatment of patients with acute coronary syndrome with ST segment elevation //Avicenna. - 2019. - No. 34. - p. 4-6.
Khorolets E. V., Shlyk S. V. Possibilities of reperfusion therapy of patients with acute myocardial infarction / / Consilium Medicum. - 2020. - Vol. 22. - No. 5.
Article Statistics
Downloads
Copyright License
Copyright (c) 2021 F. O. Khasanjanova , E. N. Tashkenbaeva, N. N. Radjabov , G. H. Khalilov, O. Urazov
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.